HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xin Yan Selected Research

O-succinylhomoserine

4/2014Modified Jiu Wei Qiang Huo decoction improves dysfunctional metabolomics in influenza A pneumonia-infected mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xin Yan Research Topics

Disease

71Neoplasms (Cancer)
11/2022 - 11/2005
13Wounds and Injuries (Trauma)
04/2022 - 10/2010
11Neoplasm Metastasis (Metastasis)
06/2022 - 06/2003
11Lung Neoplasms (Lung Cancer)
01/2022 - 01/2013
11Infections
02/2021 - 04/2014
10Pulmonary Arterial Hypertension
06/2021 - 03/2017
8Breast Neoplasms (Breast Cancer)
01/2022 - 01/2010
8Inflammation (Inflammations)
03/2020 - 11/2011
8Vascular Remodeling
02/2020 - 03/2017
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2019
7Hypoxia (Hypoxemia)
01/2021 - 01/2018
6Obesity
03/2021 - 01/2016
6Asthma (Bronchial Asthma)
01/2021 - 12/2017
6Alzheimer Disease (Alzheimer's Disease)
09/2020 - 08/2004
5Body Weight (Weight, Body)
01/2022 - 08/2017
5Ovarian Epithelial Carcinoma
06/2013 - 11/2005
4Adenocarcinoma of Lung
06/2022 - 01/2018
4Carcinogenesis
02/2022 - 01/2013
4COVID-19
01/2022 - 07/2020
4Renal Cell Carcinoma (Grawitz Tumor)
07/2021 - 01/2020
4Prostatic Neoplasms (Prostate Cancer)
06/2021 - 03/2008
4Fibrosis (Cirrhosis)
03/2021 - 07/2015
4Hemorrhage
02/2021 - 01/2014
4Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 01/2019
4Stomach Neoplasms (Stomach Cancer)
01/2019 - 06/2003
3Hematologic Neoplasms (Hematological Malignancy)
11/2022 - 01/2021
3Stroke (Strokes)
07/2022 - 04/2015
3Cardiotoxicity
01/2022 - 11/2018
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 07/2014
3Disease Progression
11/2021 - 02/2018
3Necrosis
10/2021 - 08/2012
3Ovarian Neoplasms (Ovarian Cancer)
07/2021 - 11/2005
3Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2021 - 01/2018
3Glioma (Gliomas)
01/2021 - 08/2011
3Glioblastoma (Glioblastoma Multiforme)
01/2021 - 10/2019
3Cognitive Dysfunction
09/2020 - 08/2004
3Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
05/2020 - 06/2015
3Lung Injury
01/2020 - 04/2014
3Ulcerative Colitis
01/2020 - 04/2014
3Type 2 Diabetes Mellitus (MODY)
01/2020 - 09/2017
3Carcinoma (Carcinomatosis)
01/2018 - 11/2005
3Colorectal Neoplasms (Colorectal Cancer)
01/2015 - 01/2013
3Ganglion Cysts (Ganglion)
11/2014 - 08/2010
3Psoriasis (Pustulosis Palmaris et Plantaris)
07/2014 - 09/2013
3Keloid
11/2006 - 01/2006
2Edema (Dropsy)
10/2022 - 01/2016
2Malaria
07/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

32Proteins (Proteins, Gene)FDA Link
06/2022 - 10/2010
15Pharmaceutical PreparationsIBA
01/2022 - 01/2017
15Biomarkers (Surrogate Marker)IBA
07/2021 - 04/2014
13Messenger RNA (mRNA)IBA
01/2021 - 11/2005
12MicroRNAs (MicroRNA)IBA
07/2022 - 01/2013
11Biological ProductsIBA
01/2022 - 06/2003
7Glucose (Dextrose)FDA LinkGeneric
01/2022 - 04/2012
7RNA (Ribonucleic Acid)IBA
01/2022 - 11/2013
6LipidsIBA
03/2021 - 01/2017
6MonocrotalineIBA
02/2020 - 03/2017
5CytokinesIBA
11/2022 - 04/2014
5CollagenIBA
01/2022 - 01/2014
5Therapeutic UsesIBA
12/2021 - 01/2015
5DNA (Deoxyribonucleic Acid)IBA
12/2021 - 11/2005
5Long Noncoding RNAIBA
01/2021 - 01/2018
4LigandsIBA
11/2022 - 06/2015
4Leucine (L-Leucine)FDA Link
01/2022 - 04/2014
4Immune Checkpoint InhibitorsIBA
01/2022 - 01/2020
4sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2021 - 10/2018
4Polysaccharides (Glycans)IBA
10/2020 - 01/2009
4Hematoxylin (Haematoxylon)IBA
06/2020 - 03/2017
4Eosine Yellowish-(YS) (Eosin)IBA
06/2020 - 03/2017
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2017 - 10/2010
3Phosphotransferases (Kinase)IBA
01/2022 - 09/2014
3Streptozocin (Streptozotocin)FDA Link
01/2022 - 02/2018
3Antiviral Agents (Antivirals)IBA
01/2022 - 01/2019
3AutoantibodiesIBA
01/2022 - 04/2015
3ErbB Receptors (EGF Receptor)IBA
11/2021 - 01/2015
3AntioxidantsIBA
10/2021 - 01/2020
3Reactive Oxygen Species (Oxygen Radicals)IBA
06/2021 - 07/2015
3AcidsIBA
03/2021 - 11/2011
3CateninsIBA
10/2020 - 12/2018
3Cyclin D1IBA
04/2020 - 01/2018
3CholesterolIBA
01/2019 - 11/2014
3NF-kappa B (NF-kB)IBA
09/2018 - 03/2008
3Amyloid (Amyloid Fibrils)IBA
02/2018 - 01/2018
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2018 - 09/2017
3AntibodiesIBA
06/2015 - 06/2003
2Chimeric Antigen ReceptorsIBA
11/2022 - 01/2022
2Prednisone (Sone)FDA LinkGeneric
10/2022 - 02/2018
2SesquiterpenesIBA
07/2022 - 01/2021
2artemisinin (artemisinine)IBA
07/2022 - 01/2021
2InterferonsIBA
06/2022 - 09/2018
2Cisplatin (Platino)FDA LinkGeneric
06/2022 - 01/2021
2Ethanol (Ethyl Alcohol)IBA
04/2022 - 11/2011

Therapy/Procedure

25Therapeutics
10/2022 - 01/2006
12Drug Therapy (Chemotherapy)
06/2022 - 02/2011
8Immunotherapy
02/2022 - 04/2015
7Qigong (Qi Gong)
06/2021 - 01/2006
4Radiotherapy
09/2021 - 01/2020
4Chinese Traditional Medicine (Traditional Chinese Medicine)
09/2020 - 04/2014
3Cytoreduction Surgical Procedures
02/2011 - 11/2005
2Length of Stay
07/2022 - 01/2021